Patrick Dougherty, PhD: key facts
- Kind of voice
- Academic
- Role
- Professor of Pain Medicine at The University of Texas MD Anderson Cancer Center
- Quoted on
- Cancer
- Tracked press citations
- 3
- Most recently quoted
- 30 Sept 2026
- First quoted
- 29 Sept 2026
“Psilocybin does more than reduce pain signals by protecting the nerves, themselves, through energy delivery. This neuroprotective effect could help patients withstand the stress of chemotherapy, maintaining sensation, mobility and quality of life during treatment and long into survivorship.”
What Patrick Dougherty, PhD has said
“This is the first time where psilocybin has been used as a neuroprotective agent”
Professor at the University of Texas MD Anderson Cancer Center · Cancer · 30 Sept 2026 · ‘Unparalleled’ study finds psilocybin protects against nerve damage from chemotherapy ↗
“Psilocybin does more than reduce pain signals by protecting the nerves, themselves, through energy delivery. This neuroprotective effect could help patients withstand the stress of chemotherapy, maintaining sensation, mobility and quality of life during treatment and long into survivorship.”
Professor of Pain Medicine at The University of Texas MD Anderson Cancer Center · Cancer · 29 Sept 2026 · Psilocybin Prevents Chemotherapy-Related Nerve Injury in Mice ↗
Where Patrick Dougherty, PhD has been quoted
- Psilocybin prevents chemotherapy-related nerve injury and associated symptoms in preclinical modelsmdanderson.org · 30 Sept 2026
- ‘Unparalleled’ study finds psilocybin protects against nerve damage from chemotherapyscientificamerican.com · 30 Sept 2026
- Psilocybin Prevents Chemotherapy-Related Nerve Injury in Micecancerhealth.com · 29 Sept 2026
Related media coverage
Recent UK press coverage of their topics — not necessarily citing them directly.
Professors, researchers and think-tank analysts quoted on the strength of their research rather than a clinical role. Citations are counted by an automated scan of UK press coverage and may be incomplete. Roles, biographies and contact details are researched and human-reviewed before they appear here; anything not yet reviewed is simply absent rather than shown unverified. This profile was last updated on 5 Oct 2026. See the methodology for how this page is built, or email contact@bridgeheadcommunications.com to correct anything on it.